chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Cognitive disorder, Condition aggravated, Pyrexia
Clinical narrative: Severe elbow pain. Started with dose 1, got much worse with dose 2; Severe elbow pain. Started with dose 1, got much worse with dose 2; Fevers; loss of cognitive functions; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2, Solution for injection), administered in arm left, administration date 21Jul2021 09:30 (Lot number: EW0177) at the age of 44 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Autism" (unspecified if ongoing); "Back pain" (unspecified if ongoing); "Knee arthritis" (unspecified if ongoing); "Gastro" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Sleep" (unspecified if ongoing); "Pain" (unspecified if ongoing); "Known Allergies: Penicillin" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Ceclor, reaction(s): "Known allergies: Ceclor"; Benadryl, reaction(s): "Known allergies: Benadryl"; Lexapro, reaction(s): "Known allergies: Lexapro". Vaccination history included: Bnt162b2 (Dose 1, product=COVID 19 , Brand: Pfizer Biotech COVID-19 vaccine EUA, Lot number: Ew0177, Administration time: 10:45 AM, Anatomical location: Left arm), administration date: 30Jun2021, when the patient was 44 years old, for COVID-19 Immunization, reaction(s): "Severe elbow pain". The following information was reported: ARTHRALGIA (non-serious), CONDITION AGGRAVATED (non-serious) all with onset Jul2021, outcome "not recovered" and all described as "Severe elbow pain. Started with dose 1, got much worse with dose 2"; PYREXIA (non-serious) with onset Jul2021, outcome "not recovered", described as "Fevers"; COGNITIVE DISORDER (non-serious) with onset Jul2021, outcome "not recovered", described as "loss of cognitive functions". The events "severe elbow pain. started with dose 1, got much worse with dose 2", "severe elbow pain. started with dose 1, got much worse with dose 2", "fevers" and "loss of cognitive functions" were evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of arthralgia, condition aggravated, pyrexia, cognitive disorder. Additional information: Patient was administered most recent covid-19 vaccine in Public Health Clinic/Veterans Administration facility. patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with covid-19 prior to vaccination nor after vaccination.  Follow-up attempts completed. No further information expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Dizziness, Illness, Myalgia
Clinical narrative: Dizzy sick for 2 days; Dizzy sick for 2 days; chills; nausea; fever; sore muscles; upset stomach; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm, administration date 07Aug2021 10:00 (Batch/Lot number: FC318D) at the age of 64 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose of vaccine, lot number: FA6780, left arm), when the patient was 64 years old, for COVID-19 Immunisation. The following information was reported: CHILLS (non-serious) with onset 07Aug2021 21:00, outcome "recovered" (09Aug2021), described as "chills"; NAUSEA (non-serious) with onset 07Aug2021 21:00, outcome "recovered" (09Aug2021), described as "nausea"; PYREXIA (non-serious) with onset 07Aug2021 21:00, outcome "recovered" (09Aug2021), described as "fever"; MYALGIA (non-serious) with onset 07Aug2021 21:00, outcome "recovered" (09Aug2021), described as "sore muscles"; ABDOMINAL DISCOMFORT (non-serious) with onset 07Aug2021 21:00, outcome "recovered" (09Aug2021), described as "upset stomach"; DIZZINESS (non-serious), ILLNESS (non-serious), outcome "recovering" and all described as "Dizzy sick for 2 days". Therapeutic measures were not taken as a result of chills, nausea, pyrexia, myalgia, abdominal discomfort.  Additional information: Facility type vaccine was pharmacy or drug store. No other vaccine in four weeks. No other medications in two weeks. No covid prior vaccination. No covid prior vaccination. Not tested for covid post vaccination. No known allergies. Chills, Fever, upset stomach, dizzy sick for 2 days felt better on 3rd day but did not do anything, walked around hoose. No problem with first shot.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Dizzy sick for 2 days; Dizzy sick for 2 days; chills; nausea; fever; sore muscles; upset stomach; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm, administration date 07Aug2021 10:00 (Batch/Lot number: FC318D) at the age of 64 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose of vaccine, lot number: FA6780, left arm), when the patient was 64 years old, for COVID-19 Immunisation. The following information was reported: CHILLS (non-serious) with onset 07Aug2021 21:00, outcome "recovered" (09Aug2021), described as "chills"; NAUSEA (non-serious) with onset 07Aug2021 21:00, outcome "recovered" (09Aug2021), described as "nausea"; PYREXIA (non-serious) with onset 07Aug2021 21:00, outcome "recovered" (09Aug2021), described as "fever"; MYALGIA (non-serious) with onset 07Aug2021 21:00, outcome "recovered" (09Aug2021), described as "sore muscles"; ABDOMINAL DISCOMFORT (non-serious) with onset 07Aug2021 21:00, outcome "recovered" (09Aug2021), described as "upset stomach"; DIZZINESS (non-serious), ILLNESS (non-serious), outcome "recovering" and all described as "Dizzy sick for 2 days". Therapeutic measures were not taken as a result of chills, nausea, pyrexia, myalgia, abdominal discomfort.  Additional information: Facility type vaccine was pharmacy or drug store. No other vaccine in four weeks. No other medications in two weeks. No covid prior vaccination. No covid prior vaccination. Not tested for covid post vaccination. No known allergies. Chills, Fever, upset stomach, dizzy sick for 2 days felt better on 3rd day but did not do anything, walked around hoose. No problem with first shot.  No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Cough, Fatigue, Feeling cold, Hot flush
Clinical narrative: cold like symptoms; tired; has soreness at vaccination site; has hot and cold flashes; has hot and cold flashes; coughing; wheezing/Mild Wheezing; arm soreness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 23 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 06Aug2021 (Batch/Lot number: unknown) at the age of 23 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: use her asthma inhalers if needed. The patient's concomitant medications were not reported.  The following information was reported: FATIGUE (non-serious) with onset 07Aug2021, outcome "unknown", described as "tired"; VACCINATION SITE PAIN (non-serious) with onset 07Aug2021, outcome "unknown", described as "has soreness at vaccination site"; HOT FLUSH (non-serious), FEELING COLD (non-serious) all with onset 07Aug2021, outcome "unknown" and all described as "has hot and cold flashes"; COUGH (non-serious) with onset 07Aug2021, outcome "unknown", described as "coughing"; WHEEZING (non-serious) with onset 07Aug2021, outcome "unknown", described as "wheezing/Mild Wheezing"; PAIN IN EXTREMITY (non-serious) with onset 07Aug2021, outcome "unknown", described as "arm soreness"; NASOPHARYNGITIS (non-serious) with onset 08Aug2021, outcome "unknown", described as "cold like symptoms". The events "tired", "has soreness at vaccination site", "has hot and cold flashes", "has hot and cold flashes", "coughing", "wheezing/mild wheezing", "arm soreness" and "cold like symptoms" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of fatigue, vaccination site pain, hot flush, feeling cold, cough, wheezing, pain in extremity.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Doctor's office/urgent care. Reporter cousin called tonight to report that she took the Pfizer vaccine on Friday at her doctor's office and is not feeling. She stated she was very tired, has soreness at vaccination site, has hot and cold flashes, coughing and wheezing. She called her doctor who advised her to go to urgent care tonight. She said symptoms started Saturday morning when she woke up tired and with arm soreness. She was seen by a physician at urgent care last night. She was tested for COVID and the results were negative. The physician stated that she had cold like symptoms, her blood pressure was normal and had mild wheezing. She was instructed to rest, drink plenty of fluids and use her asthma inhalers if needed. She has a history of asthma.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain in extremity, SARS-CoV-2 test, Vaccination site pain, Wheezing
Clinical narrative: cold like symptoms; tired; has soreness at vaccination site; has hot and cold flashes; has hot and cold flashes; coughing; wheezing/Mild Wheezing; arm soreness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 23 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 06Aug2021 (Batch/Lot number: unknown) at the age of 23 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: use her asthma inhalers if needed. The patient's concomitant medications were not reported.  The following information was reported: FATIGUE (non-serious) with onset 07Aug2021, outcome "unknown", described as "tired"; VACCINATION SITE PAIN (non-serious) with onset 07Aug2021, outcome "unknown", described as "has soreness at vaccination site"; HOT FLUSH (non-serious), FEELING COLD (non-serious) all with onset 07Aug2021, outcome "unknown" and all described as "has hot and cold flashes"; COUGH (non-serious) with onset 07Aug2021, outcome "unknown", described as "coughing"; WHEEZING (non-serious) with onset 07Aug2021, outcome "unknown", described as "wheezing/Mild Wheezing"; PAIN IN EXTREMITY (non-serious) with onset 07Aug2021, outcome "unknown", described as "arm soreness"; NASOPHARYNGITIS (non-serious) with onset 08Aug2021, outcome "unknown", described as "cold like symptoms". The events "tired", "has soreness at vaccination site", "has hot and cold flashes", "has hot and cold flashes", "coughing", "wheezing/mild wheezing", "arm soreness" and "cold like symptoms" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of fatigue, vaccination site pain, hot flush, feeling cold, cough, wheezing, pain in extremity.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Doctor's office/urgent care. Reporter cousin called tonight to report that she took the Pfizer vaccine on Friday at her doctor's office and is not feeling. She stated she was very tired, has soreness at vaccination site, has hot and cold flashes, coughing and wheezing. She called her doctor who advised her to go to urgent care tonight. She said symptoms started Saturday morning when she woke up tired and with arm soreness. She was seen by a physician at urgent care last night. She was tested for COVID and the results were negative. The physician stated that she had cold like symptoms, her blood pressure was normal and had mild wheezing. She was instructed to rest, drink plenty of fluids and use her asthma inhalers if needed. She has a history of asthma.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Nasopharyngitis
Clinical narrative: a little chest tightness like when I breath deeply; Feels more like I don't know like the start of a cold or cough would; Feels more like I don't know like the start of a cold or cough would; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Aug2021 11:30 (Lot number: FA7485) at the age of 25 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Stage 1 heart failure" (unspecified if ongoing), notes: I have stage 1 heart failure.". The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose, Lot no: FA7485, first dose was at 4 pm, Anatomical site of injection: Left Arm), administration date: 17Jul2021, when the patient was 25 years old, for Covid-19 Immunization.  The following information was reported: CHEST DISCOMFORT (non-serious) with onset 07Aug2021, outcome "not recovered", described as "a little chest tightness like when I breath deeply"; NASOPHARYNGITIS (non-serious), COUGH (non-serious) all with onset 07Aug2021, outcome "unknown" and all described as "Feels more like I don't know like the start of a cold or cough would". Therapeutic measures were not taken as a result of chest discomfort, nasopharyngitis, cough.  Additional information: Vaccination Facility details consumer stated, I know that it was Pharmacy. When probed if consumer administered any vaccination 4 weeks prior to COVID 19 Vaccine, Consumer stated, No. Family medical history related: Consumer stated, "Not to my knowledge." Confirmed the onset of event as yesterday 4 O'clock. Patient got the vaccine (COVID 19 Vaccine) Saturday. Yesterday I felt okay 'after receiving' it but yesterday evening, she had kind of start feeling a little chest tightness like when she breath deeply and she was feeling the same today. Further stated that like it's not like allergic reaction but it's feels more like I don't know like the start of a cold or cough would. The patient had questions about that because I mean I work with children, that was my concern.  Follow-up attempts are completed. No further information is expected.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: He is coughing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 16 year-old male patient received bnt162b2 (BNT162B2), administration date 29Jul2021 (Lot number: EW0180) at the age of 16 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: COUGH (non-serious) with onset Jul2021, outcome "unknown", described as "He is coughing".  Additional information: It was reported that they had a question my son took the shot a week ago on Friday. Well he went through all the, some of the symptoms that he was supposed to, on the left side he supposed to have but the coughing still existed, he was coughing. Confirmed the name of the vaccine as Pfizer COVID 19 Vaccine, Reporter stated that this was the paper that they gave him, so he called. Reporter stated that the event started on monday, it was end of Jul. So, the '2nd' he started having like cough. Expiration date was reported as 19Aug2021 to 02Sep2021, 09Aug, 21Sep 2nd, 21 (further not clarified). When confirmed the indication as prevention from the pandemic of COVID 19, reporter stated, that he took it, actually the day was 29Jul2021.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Increased tendency to bruise
Clinical narrative: Headache; I start bruising very easily; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 14Jul2021 14:00 (Lot number: EW0173) at the age of 36 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing), notes: No. There were no concomitant medications. The following information was reported: HEADACHE (non-serious) with onset 15Jul2021, outcome "unknown", described as "Headache"; INCREASED TENDENCY TO BRUISE (non-serious) with onset 2021, outcome "unknown", described as "I start bruising very easily". Therapeutic measures were taken as a result of headache, increased tendency to bruise.  Additional information: No vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine. She took Tylenol and for bruising she just put her heating pad on it. Her husband experienced chills only after receiving the vaccine. Both doses were at 2 o clock in the evening, received both doses one the same shoulder, on her right shoulder. On 09Aug2021 she went a little late because she was scared to take the second one because of what happened with the first one.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site haemorrhage, Vaccination site mass, Vaccination site pain
Clinical narrative: bleeding in the injection site at the left arm; sore and got a bruise that developed yesterday on the left arm; puffy  for day, kind of a lump there; she was sore normally; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm left (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE HAEMORRHAGE (non-serious), outcome "unknown", described as "bleeding in the injection site at the left arm"; VACCINATION SITE BRUISING (non-serious), outcome "unknown", described as "sore and got a bruise that developed yesterday on the left arm"; VACCINATION SITE MASS (non-serious), outcome "unknown", described as "puffy  for day, kind of a lump there"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "she was sore normally".  Additional Information: The caller is concerned about the symptoms she experienced after getting a dose of the Pfizer COVID-19 vaccine. She had bleeding on the site, and bruising after the injection. The caller declined to provide any information about if this was her first or second dose, no dates were provided. The agent already provided the number to Pfizer. The caller is wanting to know the research for the blood clotting disorder after administration of the vaccine. She added that she knows someone that experienced blood clotting after the administration of the COVID-19 vaccine but she doesn't know what type of COVID-19 vaccine that person took. The caller is asking for the data. Upon transfer, the caller declines to complete a report stating she has questions about the drug and she doesn't want to be involved. All she wants to know is more information about side effects and about the blood clotting disorder. She just has a bruise and wants to know if its normal. She doesn't want to make an official report or anything. Patient details: Declined to provide any details. Reporter details: Declined to provide any details. However, right after she was injected with the COVID-19 vaccine, she experienced a lot of bleeding. She is not on blood thinners and the person who administered the vaccine asked if she was and she informed him she was not. The bleeding did stop. She was sore normally, which was expected, but she got a bruise as well. She read if she was injected incorrectly, a blood clotting disorder can form. She doesn't know if it was injected incorrectly or intramuscularly, she didn't watch the person.   No follow up attempts are possible; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysphonia, Fatigue, Gait disturbance, Heart rate
Clinical narrative: I was a little lightheaded right after the shot; Within an hour, I was having significant muscle weakness; It was difficult to walk; My heart rate was around 100 according to the finger monitor I have at home; my skin is itchy; I have a lot of congestion in my throat; I can´t project my voice normally; arm pain; tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 10Aug2021 19:15 (Lot number: fc3180) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia" (unspecified if ongoing); "MCS" (unspecified if ongoing); "Latex" (unspecified if ongoing); "pseudocholinesterase" (unspecified if ongoing), notes: I also have pseudocholinesterase deficiency. Concomitant medication(s) included: AMOXICILLIN. Past drug history included: Chlorine, reaction(s): "allergy". The following information was reported: DIZZINESS (non-serious) with onset 10Aug2021 20:00, outcome "not recovered", described as "I was a little lightheaded right after the shot"; MUSCULAR WEAKNESS (non-serious) with onset 10Aug2021 20:00, outcome "not recovered", described as "Within an hour, I was having significant muscle weakness"; GAIT DISTURBANCE (non-serious) with onset 10Aug2021 20:00, outcome "not recovered", described as "It was difficult to walk"; HEART RATE INCREASED (non-serious) with onset 10Aug2021 20:00, outcome "not recovered", described as "My heart rate was around 100 according to the finger monitor I have at home"; PRURITUS (non-serious) with onset 10Aug2021 20:00, outcome "not recovered", described as "my skin is itchy"; RESPIRATORY TRACT CONGESTION (non-serious) with onset 10Aug2021 20:00, outcome "not recovered", described as "I have a lot of congestion in my throat"; DYSPHONIA (non-serious) with onset 10Aug2021 20:00, outcome "not recovered", described as "I can´t project my voice normally"; PAIN IN EXTREMITY (non-serious) with onset 10Aug2021 20:00, outcome "not recovered", described as "arm pain"; FATIGUE (non-serious) with onset 10Aug2021 20:00, outcome "not recovered", described as "tiredness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness, muscular weakness, gait disturbance, heart rate increased, pruritus, respiratory tract congestion, dysphonia, pain in extremity, fatigue.  Additional Information: The events onset latency was 45 min after vaccination. Facility type vaccine: Pharmacy or Drug Store. The patient did not received other vaccine in four weeks. Patient had took Benedryl. I did not have insurance, and I can't afford to see a doctor. It is my understanding that vaccine manufacturers have no liability, so that pretty much excludes the possibility of medical care for me.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Woke up this morning with hip pain/just a dull pain on either side of my hips; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 54 year-old male patient received bnt162b2 (BNT162B2), administration date 06Aug2021 13:00 (Batch/Lot number: unknown) at the age of 54 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious) with onset 11Aug2021, outcome "unknown", described as "Woke up this morning with hip pain/just a dull pain on either side of my hips". Additional information: Caller received the first dose of the Pfizer covid 19 vaccine and stated he had a couple little side effects, on day five. Caller states he received the first dose last Friday at 1pm, he is at day 5 now, woke up this morning with hip pain. Caller states, they gave me 5 sheets when he received the vaccine and joint pain was one of the side effects, it was at my waist. Is that one of the side effects, pain in hips. Caller asks the pain at your waistline is that considered the same. It's not that bad, just a dull pain on either side of my hips. Caller states he did not want to report at this time, and he was not sure if it is even related to the vaccine or not and states, maybe he slept wrong and woke up with hip pain. When asked if the side effects start later than a couple of days and how long do side effects last. Patient responded that side effects that patient may experience throughout the rest of his body (systemic side effects) were observed with the first 1 to 2 days after vaccination and resolved shortly thereafter.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Nausea, Palpitations
Clinical narrative: headache; nausea; S.O.B.; racing heart; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 05Jul2021 (Lot number: EW0217) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1st, Date (dd-Mmm-yyyy): 10Jun2021, Time (24hr): 12:10, Anatomical Site of injection: left deltoid muscle, Route of administration: Intramuscular, Batch/Lot number: Pfizer EW0172, 1st dose:, 1) Headache, 2) S.O.B, 3) Racing Heart, 4) Nausea, 5) Lethargy), administration date: 10Jun2021, when the patient was 66 years old, for Covid-19 immunization, reaction(s): "Headache", "SOB", "Racing heart", "Nausea", "lethargy". The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; DYSPNOEA (non-serious), outcome "unknown", described as "S.O.B."; PALPITATIONS (non-serious), outcome "unknown", described as "racing heart".  Follow-up attempts are completed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nasal congestion, Pain, Paranasal sinus discomfort, Pyrexia
Clinical narrative: sinus pressure started; congestion; pounding headache; fevers lasting almost  2 days; I could not get out of bed, a lot of aches as well; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 06Aug2021 11:00 (Lot number: FA7485) at the age of 45 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid-19", start date: 2020 (unspecified if ongoing); "High fever", start date: 2020 (unspecified if ongoing); "lots of aches", start date: 2020 (unspecified if ongoing); "cough", start date: 2020 (unspecified if ongoing); "congestion", start date: 2020 (unspecified if ongoing). There were no concomitant medications. Past drug history included: Vitamin d supplements, notes: Verbatim:  I take vitamin D supplements, along, with other vitamins like C from time to time.; Vitamin c, notes: Verbatim:  I take vitamin D supplements, along, with other vitamins like C from time to time. The following information was reported: PARANASAL SINUS DISCOMFORT (non-serious) with onset 09Aug2021, outcome "recovering", described as "sinus pressure started"; PAIN (non-serious) with onset 07Aug2021, outcome "recovering", described as "I could not get out of bed, a lot of aches as well"; NASAL CONGESTION (non-serious) with onset 09Aug2021, outcome "recovering", described as "congestion"; HEADACHE (non-serious) with onset 07Aug2021, outcome "recovering", described as "pounding headache"; PYREXIA (non-serious) with onset 07Aug2021, outcome "recovering", described as "fevers lasting almost  2 days". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of paranasal sinus discomfort, pain, nasal congestion, headache, pyrexia.  Additional information: Patient did not received other vaccine in four weeks and Other medications in two weeks. No Covid prior vaccination. Patient was not Covid tested post vaccination. No known allergies. Patient had Covid last year, with high fevers,lots of aches, cough, congestion. well finally decided to get the vaccine and had fevers lasting almost 2 days along with pounding headache, She could not get out of bed, a lot of aches as well, it was very scary. On day three the congestion and sinus pressure started. On day 5. She have had to miss work, She felt better but she was still congested but no fevers. Her husband had the vaccine same day he only had a sore arm, nothing else. Other medical history: Her covid diagnosis was in 2020. with her annual visit she still had antibodies. She do not have any chronic conditions and not on any chronic medications. She took vitamin D supplements, along with other vitamins like C from time to time.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test
Clinical narrative: sinus pressure started; congestion; pounding headache; fevers lasting almost  2 days; I could not get out of bed, a lot of aches as well; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 06Aug2021 11:00 (Lot number: FA7485) at the age of 45 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid-19", start date: 2020 (unspecified if ongoing); "High fever", start date: 2020 (unspecified if ongoing); "lots of aches", start date: 2020 (unspecified if ongoing); "cough", start date: 2020 (unspecified if ongoing); "congestion", start date: 2020 (unspecified if ongoing). There were no concomitant medications. Past drug history included: Vitamin d supplements, notes: Verbatim:  I take vitamin D supplements, along, with other vitamins like C from time to time.; Vitamin c, notes: Verbatim:  I take vitamin D supplements, along, with other vitamins like C from time to time. The following information was reported: PARANASAL SINUS DISCOMFORT (non-serious) with onset 09Aug2021, outcome "recovering", described as "sinus pressure started"; PAIN (non-serious) with onset 07Aug2021, outcome "recovering", described as "I could not get out of bed, a lot of aches as well"; NASAL CONGESTION (non-serious) with onset 09Aug2021, outcome "recovering", described as "congestion"; HEADACHE (non-serious) with onset 07Aug2021, outcome "recovering", described as "pounding headache"; PYREXIA (non-serious) with onset 07Aug2021, outcome "recovering", described as "fevers lasting almost  2 days". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of paranasal sinus discomfort, pain, nasal congestion, headache, pyrexia.  Additional information: Patient did not received other vaccine in four weeks and Other medications in two weeks. No Covid prior vaccination. Patient was not Covid tested post vaccination. No known allergies. Patient had Covid last year, with high fevers,lots of aches, cough, congestion. well finally decided to get the vaccine and had fevers lasting almost 2 days along with pounding headache, She could not get out of bed, a lot of aches as well, it was very scary. On day three the congestion and sinus pressure started. On day 5. She have had to miss work, She felt better but she was still congested but no fevers. Her husband had the vaccine same day he only had a sore arm, nothing else. Other medical history: Her covid diagnosis was in 2020. with her annual visit she still had antibodies. She do not have any chronic conditions and not on any chronic medications. She took vitamin D supplements, along with other vitamins like C from time to time.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Peripheral swelling
Clinical narrative: her feet are all swelled up/her left arm swelled up too; She has lost memory; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 65 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Jul2021 (Lot number: FA7458) at the age of 65 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "anemic" (unspecified if ongoing), notes: that one she has had all her life.; "bad bladder and cannot hold her pee/ peeing on herself" (unspecified if ongoing), notes: Started 25 years ago. Concomitant medication(s) included: OXYBUTIN taken for hypertonic bladder. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset Jul2021, outcome "not recovered", described as "her feet are all swelled up"; AMNESIA (non-serious) with onset Jul2021, outcome "unknown", described as "She has lost memory".  Additional information: Patient's husband reported  that after receiving the vaccine, patient's feet were all swelled up. The patient was handicapped and has been for 20 years. Reporter is her guardian and takes care of her. She has lost memory and never had lost memory before getting the vaccine. She was anemic and that one she has had all her life. Reporter provided her name as withheld and she has the same address and phone as him. Reporter stated her feet swelled up same date his symptoms started, which was 2 weeks ago and said they look bad. Caller said his wife's feet swelled up and never went down, she put ice on it and it never went down. Reporter also said her left arm swelled up too. It started two weeks ago. The patient took Oxybutin 10mg for her bladder and told pharmacy that too before getting the vaccination, they said it would not be a problem. The patient has been on oxybutin for 25 years. The reporter wanted Pfizer to compensate both he and his girlfriend for what has happened.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Confusional state, Dizziness, Fatigue
Clinical narrative: Strange smell; Strange taste; Dizziness; Confusion lasting about 1 hour; Sore kidneys; Sore back; Sore muscles; Sore joints; Swollen glands in throat; Fatigue; Difficulty sleeping. lasting 20 hours.; Lethargy; soreness; extreme muscle tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 29Jul2021 08:30 (Lot number: EW0183) at the age of 53 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Coeliac disease" (unspecified if ongoing); "Allergy to eggs" (unspecified if ongoing); "Allergy to dairy" (unspecified if ongoing); "Allergy to Gluten" (unspecified if ongoing); "Allergy to soy" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing); "Latex allergy" (unspecified if ongoing). Concomitant medication(s) included: IBUPROFEN. The following information was reported: PAROSMIA (non-serious) with onset 29Jul2021, outcome "recovered", described as "Strange smell"; TASTE DISORDER (non-serious) with onset 29Jul2021, outcome "recovered", described as "Strange taste"; DIZZINESS (non-serious) with onset 2021, outcome "recovered", described as "Dizziness"; CONFUSIONAL STATE (non-serious) with onset 2021, outcome "recovered", described as "Confusion lasting about 1 hour"; RENAL PAIN (non-serious) with onset 2021, outcome "recovered", described as "Sore kidneys"; BACK PAIN (non-serious) with onset 2021, outcome "recovered", described as "Sore back"; MYALGIA (non-serious) with onset 2021, outcome "recovered", described as "Sore muscles"; ARTHRALGIA (non-serious) with onset 2021, outcome "recovered", described as "Sore joints"; PHARYNGEAL SWELLING (non-serious) with onset 2021, outcome "recovered", described as "Swollen glands in throat"; FATIGUE (non-serious) with onset 2021, outcome "recovered", described as "Fatigue"; INSOMNIA (non-serious) with onset 2021, outcome "recovered", described as "Difficulty sleeping. lasting 20 hours."; LETHARGY (non-serious) with onset 2021, outcome "recovered", described as "Lethargy"; PAIN (non-serious) with onset 2021, outcome "recovered", described as "soreness"; MUSCLE FATIGUE (non-serious) with onset 2021, outcome "recovered", described as "extreme muscle tiredness". Therapeutic measures were not taken as a result of parosmia, taste disorder, dizziness, confusional state, renal pain, back pain, myalgia, arthralgia, pharyngeal swelling, fatigue, insomnia, lethargy, pain, muscle fatigue.  Additional information: patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. Vaccine was administered IN Doctor's office/urgent care.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Lethargy, Muscle fatigue, Myalgia, Pain
Clinical narrative: Strange smell; Strange taste; Dizziness; Confusion lasting about 1 hour; Sore kidneys; Sore back; Sore muscles; Sore joints; Swollen glands in throat; Fatigue; Difficulty sleeping. lasting 20 hours.; Lethargy; soreness; extreme muscle tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 29Jul2021 08:30 (Lot number: EW0183) at the age of 53 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Coeliac disease" (unspecified if ongoing); "Allergy to eggs" (unspecified if ongoing); "Allergy to dairy" (unspecified if ongoing); "Allergy to Gluten" (unspecified if ongoing); "Allergy to soy" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing); "Latex allergy" (unspecified if ongoing). Concomitant medication(s) included: IBUPROFEN. The following information was reported: PAROSMIA (non-serious) with onset 29Jul2021, outcome "recovered", described as "Strange smell"; TASTE DISORDER (non-serious) with onset 29Jul2021, outcome "recovered", described as "Strange taste"; DIZZINESS (non-serious) with onset 2021, outcome "recovered", described as "Dizziness"; CONFUSIONAL STATE (non-serious) with onset 2021, outcome "recovered", described as "Confusion lasting about 1 hour"; RENAL PAIN (non-serious) with onset 2021, outcome "recovered", described as "Sore kidneys"; BACK PAIN (non-serious) with onset 2021, outcome "recovered", described as "Sore back"; MYALGIA (non-serious) with onset 2021, outcome "recovered", described as "Sore muscles"; ARTHRALGIA (non-serious) with onset 2021, outcome "recovered", described as "Sore joints"; PHARYNGEAL SWELLING (non-serious) with onset 2021, outcome "recovered", described as "Swollen glands in throat"; FATIGUE (non-serious) with onset 2021, outcome "recovered", described as "Fatigue"; INSOMNIA (non-serious) with onset 2021, outcome "recovered", described as "Difficulty sleeping. lasting 20 hours."; LETHARGY (non-serious) with onset 2021, outcome "recovered", described as "Lethargy"; PAIN (non-serious) with onset 2021, outcome "recovered", described as "soreness"; MUSCLE FATIGUE (non-serious) with onset 2021, outcome "recovered", described as "extreme muscle tiredness". Therapeutic measures were not taken as a result of parosmia, taste disorder, dizziness, confusional state, renal pain, back pain, myalgia, arthralgia, pharyngeal swelling, fatigue, insomnia, lethargy, pain, muscle fatigue.  Additional information: patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. Vaccine was administered IN Doctor's office/urgent care.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Parosmia, Pharyngeal swelling, Renal pain, Taste disorder
Clinical narrative: Strange smell; Strange taste; Dizziness; Confusion lasting about 1 hour; Sore kidneys; Sore back; Sore muscles; Sore joints; Swollen glands in throat; Fatigue; Difficulty sleeping. lasting 20 hours.; Lethargy; soreness; extreme muscle tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 29Jul2021 08:30 (Lot number: EW0183) at the age of 53 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Coeliac disease" (unspecified if ongoing); "Allergy to eggs" (unspecified if ongoing); "Allergy to dairy" (unspecified if ongoing); "Allergy to Gluten" (unspecified if ongoing); "Allergy to soy" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing); "Latex allergy" (unspecified if ongoing). Concomitant medication(s) included: IBUPROFEN. The following information was reported: PAROSMIA (non-serious) with onset 29Jul2021, outcome "recovered", described as "Strange smell"; TASTE DISORDER (non-serious) with onset 29Jul2021, outcome "recovered", described as "Strange taste"; DIZZINESS (non-serious) with onset 2021, outcome "recovered", described as "Dizziness"; CONFUSIONAL STATE (non-serious) with onset 2021, outcome "recovered", described as "Confusion lasting about 1 hour"; RENAL PAIN (non-serious) with onset 2021, outcome "recovered", described as "Sore kidneys"; BACK PAIN (non-serious) with onset 2021, outcome "recovered", described as "Sore back"; MYALGIA (non-serious) with onset 2021, outcome "recovered", described as "Sore muscles"; ARTHRALGIA (non-serious) with onset 2021, outcome "recovered", described as "Sore joints"; PHARYNGEAL SWELLING (non-serious) with onset 2021, outcome "recovered", described as "Swollen glands in throat"; FATIGUE (non-serious) with onset 2021, outcome "recovered", described as "Fatigue"; INSOMNIA (non-serious) with onset 2021, outcome "recovered", described as "Difficulty sleeping. lasting 20 hours."; LETHARGY (non-serious) with onset 2021, outcome "recovered", described as "Lethargy"; PAIN (non-serious) with onset 2021, outcome "recovered", described as "soreness"; MUSCLE FATIGUE (non-serious) with onset 2021, outcome "recovered", described as "extreme muscle tiredness". Therapeutic measures were not taken as a result of parosmia, taste disorder, dizziness, confusional state, renal pain, back pain, myalgia, arthralgia, pharyngeal swelling, fatigue, insomnia, lethargy, pain, muscle fatigue.  Additional information: patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. Vaccine was administered IN Doctor's office/urgent care.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity, Pruritus, Rash, Swelling, Urticaria
Clinical narrative: allergic reactions; I have itching, swelling; I have itching, swelling; hives and breakout; had rash; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 09Aug2021 11:30 (Lot number: EW0170) at the age of 68 years as dose 1, single and intramuscular, administered in arm left, administration date 30Aug2021 11:00 (Lot number: FC3183) as dose 2, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: Verbatim: High blood pressure; "Pain" (unspecified if ongoing); "heart" (unspecified if ongoing). Concomitant medication(s) included: ELIQUIS taken for cardiac disorder; POTASSIUM; TIZANIDINE taken for pain; VITAMIN D NOS; METOPROLOL taken for blood pressure measurement; VENLAFAXINE. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "allergic reactions"; PRURITUS (non-serious), SWELLING (non-serious), outcome "unknown" and all described as "I have itching, swelling"; URTICARIA (non-serious), outcome "unknown", described as "hives and breakout"; RASH (non-serious), outcome "unknown", described as "had rash". Therapeutic measures were taken as a result of hypersensitivity, pruritus, swelling, urticaria, rash.  Additional information: The patient reported that got the Pfizer, first Pfizer, Monday and having reaction, allergic reaction to it and had itching, swelling. The patient stated that dont have it anymore, had it yesterday and the patient was retired. Treatment: The patient stated: took some Tylenol and some Benadryl and wiped out with alcohol. No other vaccination 4 weeks prior. Just taking medicine across the counter Tylenol. (Intent: Medical Information). Follow-up attempts are completed. No further information is expected. The patient reported Had rash and hives after taking both vaccines, return to health department on 21Sep2021 for booster vaccine  No follow-up attempts are possible. No further information is expected.